Xpert® MRSA NxG

Home / Tests / HAI & Other Infectious Diseases

Xpert® MRSA NxG

Active MRSA surveillance testing in around 70 minutes

Test pack size(s)

10 Tests

GXMRSA-NXG-CE-10

Qty

Unit price

Subtotal

USD

$0.00

Collection devices

Collection Device (Pack of 50)

900-0370

Qty

Unit price

Subtotal

USD

$0.00

Total

$0.00

The Need

Hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections are a major cause of morbidity and mortality worldwide¹
People with methicillin-resistant Staphylococcus aureus (MRSA) infections are 64 % more likely to die than people with drug-sensitive infections²
Active surveillance of inpatients for MRSA is a strategy for preventing health care-acquired infections (HAIs) by MRSA¹

1 Yarbrough M, et al. Multicenter evaluation of the Xpert MRSA NxG assay for detection of methicillin-resistant Staphylococcus aureus in Nasal Swabs. J Clin Microbiol. 2017 Dec;56(1).
2 World Health Organization. (n.d.). Antimicrobial resistance. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance

The Solution

Xpert^® MRSA NxG is a qualitative in-vitro diagnostic test intended for the detection of methicillin-resistant S. aureus (MRSA) DNA directly from nasal swabs in patients at risk for nasal colonization*
Quickly identify MRSA-colonized patients who require contact precautions to reduce the risk of transmission and avoid costly outbreaks

* Xpert MRSA NxG was compared to a Reference Culture Method. See Package Insert for additional details.

The Impact

Rapid implementation of infection control measures and patient bed management¹
Superior clinical performance compared to other commercial tests¹
Minutes of hands-on time with results in about 1 hour on a random-access platform¹

1 Yarbrough M, et al. Multicenter evaluation of the Xpert MRSA NxG assay for detection of methicillin-resistant Staphylococcus aureus in Nasal Swabs. J Clin Microbiol. 2017 Dec;56(1).